FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:624-626 August 10, 2006 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Gold, D. R. Related Article by Guilbert, T. W. Related Article by Bisgaard, H. PubMed Citation

To the Editor: Guilbert and colleagues and Bisgaard and colleagues (May 11 issue)^1,2 investigated the effect of inhaled corticosteroids in infants and preschool children with wheezing or an increased risk of asthma. The two studies, at best, found a marginal benefit in the inhaled-corticosteroid group, as compared with the placebo group. The treatment effect appeared to be somewhat stronger in the preschool cohort studied by Guilbert et al.

Guilbert et al. used propellant-driven metered-dose inhalers with fluticasone, and Bisgaard et al. used the same type of inhalers with budesonide, both delivered by means of a valved spacer. The particle size . . . [Full Text of this Article]

This article has been cited by other articles:

• Ermers, M. J J, Rovers, M. M, van Woensel, J. B, Kimpen, J. L L, Bont, L. J, on behalf of the RSV Corticosteroid Study Group, (2009). The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial. BMJ 338: b897-b897 [Abstract] [Full Text]